Partnering
Join us in advancing TCR-T therapies and offering new hope to patients with solid tumours. Whether you’re a researcher, investor, or patient advocate, we are always looking to partner with those who share our passion.
Partnering Opportunities
At Pan Cancer T, we are developing therapies targeting a wide range of hard-to-treat solid tumors. Our broad portfolio includes novel tumor targets, new TCRs, and a robust treatment pipeline. As we focus on advancing our lead product, PCT1:CO-STIM, to the clinic, we open up opportunities for partnerships and collaborations to develop life-changing treatments for cancers with high unmet medical needs.
Our Current Partners
Discover our potential by contacting us.